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‘Marine Biotechnology in the European Research Area: Challenges and Opportunities for Europe’ 
The CSA MarineBiotech project ( ), an ERA-NET Preparatory Action in Marine 
Biotechnology, was designed to deliver the first concrete steps towards better coordination of relevant 
national and regional Research, Technology Development and Innovation (RTDI) programmes in 
Europe, and paving the way for common programmes and cooperation in the provision and use of 
research infrastructures.  
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PREFACE  
The Coordination and Support Action in Marine Biotechnology (CSA MarineBiotech), is a collaborative 
network funded by the European Commission under the 7
th
 Framework Programme. It consists of 11 
partners from 9 countries that support marine biotechnology research and development in Europe. 
Since October 2011, the partners of the CSA MarineBiotech, with support from a growing number of 
associated stakeholders, have worked intensively to explore the opportunities and needs for European 
coordination, trans-national cooperation and joint activities in the area of marine biotechnology 
research. 
 
The CSA MarineBiotech is not without history and responds to coordination requirements identified 
during various earlier initiatives. In fact, interest in marine biotechnology from the scientific 
community, and to some extent from industry, has grown rapidly in the past decade owing to a 
recognition of the sheer scale of opportunity presented by the largely unexplored and immense 
biodiversity of our seas and oceans and the need to meet growing demands for food and energy that 
cannot be satisfied from terrestrial sources alone. The marine environment accounts for over 90% of 
the biosphere and marine biotechnology is the key to unlocking the potential of the unique 
biodiversity of marine organisms and ecosystems.  
Over the last decade, several science policy initiatives
1
 have highlighted the importance of marine 
biotechnology and its potential to make a significant contribution to sustainable development on all 
fronts, including social, economic and environmental. However, these initiatives have also identified a 
number of important barriers and challenges that will need to be tackled at various levels for Europe to 
remain a key player in marine biotechnology research. To overcome the challenges in a coordinated 
way, scientists, policy makers and industry representatives have contributed to the formulation of a 
Vision and Strategy for marine biotechnology which is widely shared by the stakeholders
2
 and provides 
key recommendations to improve collaboration and advance marine biotechnology research in 
Europe
3
.  
It is only recently that a concerted effort has been initiated in Europe to take action on many of the 
issues identified, to improve the coordination of marine biotechnology research, raise its profile, and 
contribute to the establishment of the European BioEconomy. Notably, the FP7 CSA MarineBiotech has 
been preparing the grounds for a network of funding organisations and programme managers 
interested in joint support for marine biotechnology research that aims to launch in late 2013 (if 
awarded).  
Hence, we are at a crucial time as we complete one major coordination effort to prepare for the next 
one. It is therefore very timely to take stock of the current situation and evaluate progress towards 
realising the vision and strategy for marine biotechnology in Europe and what challenges remain to 
position marine biotechnology as a key component of the European knowledge-based economy. 
To this end, the final conference of the CSA MarineBiotech project brings together scientists, industry 
representatives, policy makers/advisors and other key stakeholders involved or interested in marine 
biotechnology research in Europe, to: 
 Provide insights into some of the most important recent and ongoing marine biotechnology research, 
coordination and policy projects and initiatives, including the CSA MarineBiotech project, and look 
forward towards a future MarineBiotech ERA-NET;  
 Discuss the status and recent progress of European marine biotechnology research efforts and 
capacity at various scales; 
 Identify critical needs, gaps and challenges to inform future marine biotechnology policy and 
coordination efforts. 
 
More information about the project, its activities and outputs are available from the CSA website at 
www.marinebiotech.eu   
                                                 
1
 Major marine biotechnology science policy initiatives and events include the 2006 Bremen Meeting, the 2010 
Marine Board Working Group position paper on marine biotechnology, the European Commission Collaborative 
Working Group scoping paper on Marine Biotechnology and the EU-US Task Force on Biotechnology events.  
2
 See Marine Biotechnology: a New Vision and Strategy for Europe, Marine Board Position Paper 15 available at 
www.marineboard.eu/publications   
3
 See www.marinebiotech.eu for recommendations from Stakeholders from two CSA MarineBiotech Workshops held 
in Portugal (Faro, 26-27 April 2012) and Germany (Hamburg, 8-9 October 2012). 
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COORDINATION AND SUPPORT ACTION FOR EUROPEAN MARINE 
BIOTECHNOLOGY RESEARCH (CSA MARINEBIOTECH)  
Steinar Bergseth
1
 and Jan-Bart Calewaert
2
 on behalf of the CSA MarineBiotech Partners
3
 
1 
The Research Council of Norway, Stensberggt. 26, 131 Oslo, Norway 
E-mail: stb@rcn.no 
2
 European Marine Board (EMB), Wandelaarkaai 7, 8400 Oostende, Belgium 
E-mail: jcalewaert@esf.org   
3
 CSA MarineBiotech Partners are: The Research Council of Norway (RCN), Norway; Flanders Marine 
Institute (VLIZ), Belgium; Norgenta North German Life Science Agency (Norgenta), Germany; 
Technical University of Denmark (DTU), Denmark; Centre National de la Recherche Scientifique 
Station Biologique de Roscoff (CNRS), France; French Research Institute for Exploitation of the 
Sea (Ifremer), France; European Marine Board (EMB), Belgium; Institute for Coastal Marine 
Environment (IAMC-CNR), Italy; Fundação para a Ciência e a Tecnologia (FCT), Portugal; Scientific 
and Technological Research Council of Turkey (TÜBITAK), Turkey; BioBridge Ltd (BIOBRIDGE), 
United Kingdom. 
 
The Coordination and Support Action in Marine Biotechnology (CSA MarineBiotech), is a 
collaborative network funded by the European Commission under the 7
th
 Framework Programme 
and consisting of 11 partners from 9 countries that support marine biotechnology research and 
development in Europe. From October 2011 to March 2013, these MarineBiotech partners: (i) 
prepared the foundation for an ERA-NET in marine biotechnology; (ii) mobilised and engaged 
funding agencies and stakeholders; (iii) established a Strategic Forum and a Stakeholder Group; and 
(iv) increased the number of funding agencies involved in the partnership committed to develop an 
ERA-NET in marine biotechnology. At the basis of these efforts, the group engaged in a dedicated 
mapping exercise to obtain more information about the current marine biotechnology science 
policy landscape in Europe and internationally.  
 
One of the main achievements of the CSA MarineBiotech include the organisation of a successful 
series of networking events to assist in the mobilisation and engagement of funding agencies and 
stakeholders to guide the development of a future ERA-NET and support the dynamic marine 
biotechnology research community in Europe. Another central component of the CSA MarineBiotech 
project, is the development of a European marine biotechnology webportal (www.marinebiotech.eu). 
This portal serves both as a project website for the CSA and a long-term support tool for the 
growing marine biotechnology community in Europe by integrating dynamic and interactive 
modules and information systems, notably the MarineBiotech Infopages (WIKI) and a European 
MarineBiotech Database with projects and relevant organisations. 
 
This presentation will look back at some of the main achievements and lessons learned from the 
CSA MarineBiotech in paving the way for an ERA-NET on marine biotechnology and working towards 
a long term support mechanisms for the European marine biotechnology community. 
 
 
1
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ARE WE REALISING THE VISION AND STRATEGY FOR EUROPEAN 
MARINE BIOTECHNOLOGY RESEARCH? 
Joel Querellou 
Former Ifremer Head of Microbiology of Extreme Environments Laboratory, Ifremer 
Former Chair of the Marine Board Working Group on Marine Biotechnology, France 
E-mail: leintan@free.fr 
Marine biotechnology has been recognized as a strategic field of activity to prepare the transition 
from an oil-based economy to a bio-based economy by most of the leading countries in the world, 
from EU countries to the US, Japan, China, etc. Considering the trends that were observed during 
the first decade of this century in Europe, several initiatives have been developed in recent years. 
Marine biotechnology opportunities and challenges were thoroughly discussed within several 
Working Groups and initiatives (EU Collaborative Working Group on Marine Biotechnology, ESF-
Marine Board Working Group on Marine Biotechnology, and of course the ongoing CSA 
MarineBiotech). A new vision and an appropriate strategy were adopted and key recommendations 
proposed as major guidelines for future policies (Marine Board Position Paper 15 on Marine 
Biotechnology, CWG-MB final report).  
 
Since the publication of the ESF-MB PP15, different programmes and projects have been launched. 
Several of these projects are in perfect agreement with the recommendations or directly inspired by 
the conclusions of the ESF-MB PP15. The current initiative to implement a Marine Biotech ERA-NET is 
also an important step forward. Nevertheless, considering the economic and social crisis in EU, and 
notably the North-South gradient in the ability to fund national RTD projects, an ERA-NET is a 
necessary component of the future policy but might not be sufficient to keep national policies 
aligned during the next decade. Additional mechanisms should be discussed and the EC should 
keep a direct support to marine biotechnology research projects, in relation with health, food, 
energy and environmental policies. 
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SEA ANEMONE TOXINS: INSECTICIDES AND PAINKILLERS OF THE 
FUTURE? 
Steve Peigneur
1
, László Béress
2
, Carolina Möller
3
, Frank Marí
 3
, Wolf-Georg Forssmann
2  
and Jan Tytgat
1
 
1 
Laboratory of Toxicology, University of Leuven (KU Leuven), O&N2, PO Box 922, 3000 Leuven, 
Belgium  
E-mail: jan.tytgat@pharm.kuleuven.be  
2
 Department of Immunology and Rheumatology, Hannover Medical University, 30625 Hannover, 
Germany 
3
 Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, 33431 Florida, 
USA 
 
Nature has provided sea anemones with cells called, nematocysts, that contain a venom for 
defensive and offensive purposes. In such venom, numerous bioactive molecules (toxins) can be 
found. Since these molecules appear to be extremely potent and selective, the use of these toxins 
for purposes like pharmaceuticals (read: the development of new generations of drugs, like 
antibiotics, analgesics, ...), or agricultural compounds (read: novel generation of pesticides that are 
environmental friendly without resistance known) has triggered a strong interest. 
 
Sea anemones pray on crustaceae (like shrimps, lobsters, ...), but can also be attacked by them. So 
no wonder that nature has designed and equipped sea anemones with toxins that target crustaceae. 
Very interestingly, since crustaceae are evolutionary linked to insects, it was found that the same 
toxins from sea anemones also are effective against insects. So even when a sea anemone will never 
encounter an insect during his life, nature has engineered beautiful insecticides in the sea, and we 
can exploit these molecules to be applied/used in a different habitat/environment. 
 
The target in insects is the voltage-gated sodium (Na) channel, not surprisingly, since this target is 
also the one used by the oldest generation of insecticides like DDT. 
 
As such, the toxins found in the venom of sea anemones provide a unique resource for future 
development of new generation(s) of insecticides, with the advantage that no resistance against 
these toxins exists and moreover that they are environmentally friendly which is a clear plus point 
as compared to DDT and related molecules. 
 
In this study, particular attention was paid to APETx3, a novel peptide isolated from the sea 
anemone Anthopleura elegantissima, being a naturally occurring mutant from APETx1, only 
differing by a Thr to Pro substitution at position 3. APETx1 is believed to be a selective modulator of 
human ether-á-go-go related gene (hERG) potassium channels with a Kd of 34nM. We have subjected 
APETx1, 2, and 3 to an electrophysiological screening on a wide range of 24 ion channels expressed 
in Xenopus laevis oocytes:10 cloned voltage-gated sodium channels (NaV1.2–NaV1.8, the insect 
channels DmNaV1, BgNaV1–1a, and the arachnid channel VdNaV1) and 14 cloned voltage-gated 
potassium channels (KV1.1–KV1.6, KV2.1, KV3.1, KV4.2, KV4.3, KV7.2, KV7.4, hERG, and the insect 
channel Shaker IR). Surprisingly, the Thr3Pro substitution results in a complete abolishment of 
APETx3 modulation on hERG channels and provides this toxin the ability to become a potent (EC50 
276nM) modulator of voltage-gated sodium channels (NaVs) because it slows down the inactivation 
of mammalian and insect NaV channels. Our study also shows that the homologous toxins APETx1 
and APETx2 display promiscuous properties since they are also capable of recognizing NaV 
channels with IC50 values of 31nM and 114nM, respectively, causing an inhibition of the sodium 
conductance without affecting the inactivation. The inhibitory effects observed on particular 
isoforms of NaV channels predicts these toxins to be a novel class of analgesics. 
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FP7 MARINE METAGENOMICS FOR NEW BIOTECHNOLOGICAL 
APPLICATIONS (MAMBA) – LESSONS FROM SUCCESSFUL PAN-
EUROPEAN COLLABORATION 
Peter N. Golyshin and The MAMBA Scientific Consortium 
School of Biological Sciences, Bangor University, LL57 2UW, Wales, UK 
E-mail: p.golyshin@bangor.ac.uk  
Marine Metagenomics for new biotechnological applications (MAMBA) is a Collaborative Project, 
funded by EU within the FP7 program [1]. The MAMBA consortium is built on the expertise of 
biochemists, geneticists, microbiologists, pharmaceutical chemists and process engineers from the 
academia. It also involves three companies dealing with synthesis of fine chemicals and biocatalysis 
and bioprospecting for anti-cancer and anti-ageing agents. The project is focused on a search and 
use of new microorganisms-derived activities from marine environments that are difficult to access, 
populated by complex microbial consortia with culturable and unculturable bacterial and archaeal 
members and characterized by extreme values of hypersalinities, high/low temperatures, high 
pressure and other parameters. A number of different samples from various sites of Mediterranean 
Sea and other marine environments have been conducted for the preparation of small, medium and 
large-insert metagenomic libraries, furthermore more 1.1 thousand positive fosmids and phagemids 
have been selected after enzymatic screenings of interest with a number of most interesting items 
fully characterized. The presentation will summarize the major achievements, point at the 
bottlenecks and show possible pathways of impact of this multinational collaboration beyond the 
end of the Project.  
 
Authors thank the European Commission for its support (Contract Nr KBBE-2008-226877) 
 
 
[1]  http://mamba.bangor.ac.uk/  
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MARINE GENETIC RESOURCES AND THE LAW OF THE SEA 
Charlotte Salpin 
Division for Ocean Affairs and the Law of the Sea, Office of Legal Affairs, United Nations, New York, 
NY 10017, USA 
E-mail: salpin@un.org  
Marine biodiversity, in particular issues related to marine genetic resources, have become a central 
topic of discussions of international policy-makers and lawyers. At stake are a number of political, 
economic, social, environmental, legal and ethical interests. In recent years, in the context of the 
United Nations, States have sought to ensure the sustainable use of marine biodiversity, while at the 
same time protecting vulnerable ecosystems from various impacts. Marine biodiversity beyond 
areas of national jurisdiction is particularly vulnerable owing to the current legal and institutional 
framework, which remains sector-based. Several international instruments apply, yet none of those 
instruments specifically addresses this issue. First and foremost among those instruments is the 
United Nations Convention on the Law of the Sea (UNCLOS), which sets out the framework for all 
activities in the oceans and seas and establishes various regimes within different maritime zones. 
Several global and regional intergovernmental organisations also have sectoral competences in 
areas beyond national jurisdiction but coordination remains minimal. 
 
Discussions at the General Assembly are now seeking to ensure that the legal framework for the 
conservation and sustainable use of marine biodiversity beyond areas of national jurisdiction 
effectively addresses those issues by identifying gaps and ways forward, including through the 
implementation of existing instruments and the possible development of a multilateral agreement 
under UNCLOS. The issue of marine genetic resources of areas beyond national jurisdiction is a key 
component of the discussions, including with a view to addressing questions of access and 
equitable sharing of the benefits arising out of their utilization as well as capacity-building needs 
and technology transfer.  In the context of those discussions, Member States are to consider, inter 
alia, the extent and types of research, uses and applications of those resources, technological, 
environmental, social and economic aspects, intellectual property rights issues, as well as global 
and regional regimes on genetic resources, experiences and best practices. 
 
The presentation will provide an overview of the on-going process at the United Nations, 
highlighting the relevant legal and institutional aspects, including the rights and obligations of 
States within various maritime zones as set out under UNCLOS, issues of access and benefit sharing 
as well as intellectual property rights. 
 
 
 
General Assembly resolution 67/78, ‘Oceans and the law of the sea’, 11 December 2012. 
General Assembly resolution 66/288, ‘The future we want’, 27 July 2012. 
Letter dated 8 June 2012 from the Co-Chairs of the Ad Hoc Open-ended Informal Working Group to 
study issues relating to the conservation and sustainable use of marine biological diversity 
beyond areas of national jurisdiction, United Nations document A/67/95, 13 June 2012. 
Letter dated 30 June 2011 from the Co-Chairs of the Ad Hoc Open-ended Informal Working Group to 
the President of the General Assembly, United Nations document A/66/119, 30 June 2011. 
Letter dated 16 March 2010 from the Co-Chairpersons of the Ad Hoc Open-ended Informal Working 
Group to the President of the General Assembly, United Nations document A/65/68, 17 March 
2010.  
Report of the Ad Hoc Open-ended Informal Working Group to study issues relating to the 
conservation and sustainable use of marine biological diversity beyond areas of national 
jurisdiction: Letter dated 15 May 2008 from the Co-Chairpersons of the Ad Hoc Open-ended 
Informal Working Group to the President of the General Assembly, United Nations document 
A/63/79 and Corr.1, 16 May 2008 and 3 December 2008. 
Report of the Ad Hoc Open-ended Informal Working Group to study issues relating to the 
conservation and sustainable use of marine biological diversity beyond areas of national 
jurisdiction, United Nations document A/61/65, 20 March 2006.  
Reports of the Secretary-General, ‘Oceans and the law of the sea’, United Nations documents 
A/66/70, A/64/66/Add.2, A/62/66/Add.2 and A/60/63/Add.1. 
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MARINE BIODIVERSITY AND GENE PATENTS – BALANCING THE 
PRESERVATION OF MARINE GENETIC RESOURCES (MGR) AND THE 
EQUITABLE GENERATION OF BENEFITS FOR SOCIETY  
Arrieta J.M
1
 and C.M. Duarte
1,2
 
1 
Department of Global Change Research, Mediterranean Institute of Advanced Studies, CSIC-UIB, 
07190 Esporles, Spain 
E-mail: txetxu@imedea.uib-csic.es   
2
 Oceans Institute and School of Plant Biology, University of Western Australia, Crawley 6009, 
Australia 
 
Marine Genetic Resources have been identified and included in patent applications increasingly in 
recent decades. The number of patent applications including genes from marine organisms is 
growing at 12% per year (Arrieta et al., 2010). However, human appropriation of marine genetic 
resources is poorly regulated, particularly in international waters where no legal framework exists. 
The absence of a clear regulation about the property of MGRs results in an absence of mechanisms 
to ensure proper protection of these resources in international waters. Moreover, access to the 
World’s MGRs is limited by technological capacity. 90% of patent claims associated to genes of 
marine organisms originate from only 10 countries (Arnaud-Haond et al., 2011). Thus, there is an 
urgent need to provide a clear access and benefit-sharing framework for MGRs in international 
waters. 
 
Conversely, within the EEZ of different countries, where the property of MGRs is well established, 
the fear of biopiracy often results in too many restrictions to bioprospecting and to basic research 
in general. This fear of biopiracy could be greatly alleviated implementing specific requirements to 
disclose the geographical origin and taxonomic affiliation of the source organisms in patent 
applications involving natural genetic resources. 
 
 
Arnaud-Haond S., J.M. Arrieta and C.M. Duarte. 2011. Marine biodiversity and gene patents. Science 
331(6024):1521 –1522. 
Arrieta J.M., S. Arnaud-Haond and C.M. Duarte. 2010. What lies underneath: conserving the oceans’ 
genetic resources. Proceedings of the National Academy of Sciences 107(43):18318 –18324. 
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PANEL DISCUSSION 1  
Aligning and linking national research efforts with European 
research collaborations, challenges and developments  
: Niall McDonough 
European Marine Board, Belgium  
 
One of the aims of the future ERA-NET will be to improve the coordination of national research 
efforts. To this end this panel will bring together principal investigators/coordinators of major 
national research projects to discuss the challenges, opportunities and needs for better linking and 
for improving transnational collaboration of national research efforts at the European scale. The aim 
is to discuss specific needs and challenges for the development of marine biotechnology.  
 
Principal investigators will briefly present their major national and European research efforts 
followed by a moderated discussion culminating in a clear set of recommendations.  
 
Principal investigators or representatives from a selection of major national research endeavors and 
collaborations currently running or recently completed. Some panel members may have experience 
with regional and pan-European scientific collaborations, but this is not a prerequisite as the 
starting point is national research efforts and how they tie-in with wider scale efforts. 
 
 , University College Cork, Ireland – Beaufort Bio 
 , Immunology and Genomics Group, Institute of Marine Research, CSIC Vigo, 
Spain – AQUAGENOMICS  
 , Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), 
Luxembourg 
 , Department of Genetics and Marine Biotechnology Institute of Oceanology, 
Polish Academy of Sciences, Poland 
 , French Research Institute for Exploration of the Sea (Ifremer), France - 
Greenstars project 
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SESSION 2 
 
Academic-industry collaborations 
 
Session chair:  
                      Biobridge, UK 
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VARIETY CREATES WEALTH - (BIO)DIVERSITY AS A SOURCE OF HIGHER 
VALUE-ADDED PRODUCTS FROM MARINE LIVING RESOURCES 
Levent Piker
1,2
, Christian Koch
1,2
, Peter Krost
1,2
 and Inez Linke
2 
1 
CRM – Coastal Research & Management, Tiessenkai 12, D-24159 Kiel, Germany 
2 
oceanBASIS GmbH, Tiessenkai 12, D-24159 Kiel, Germany 
E-mail: lpiker@oceanbasis.de 
 
Two decades of R&D activities in the field of marine ecology, sustainable aquaculture and marine 
biotechnology and one decade of marketing products originating from marine living resources have 
been accomplished by the sister companies CRM – Coastal Research & Management and oceanBASIS 
GmbH, located in Kiel, Northern Germany. This presentation gives an interim balance of these 
activities and what the future could hold for Marine Biotechnology in Europe from an 
entrepreneurial and societal perspective.  
 
It will be discussed, how (bio-)diversity might play a key role for exploiting the potential of Marine 
Biotechnology on an entrepreneurial as well as on broader economic scale. 
 
We will give some examples of own economic activities within or deriving from Marine 
Biotechnology. These examples include research activities in the fields of tissue engineering, 
wound-healing, and screening of antitumoral and anti-infectious properties, but also development, 
production and marketing of seaweed and shellfish from an Integrated Multitrophic Aquaculture 
(IMTA) facility, bioactives for the cosmetic industry, and the natural cosmetics brand ‘Oceanwell’.  
A lot of people, mainly biologists, are propagating, that Marine Biotechnology as a concept will 
broadly contribute to overcome societal challenges, therefore raising high expectations. There are 
some supporting arguments for this point of view. However, whereas Marine Biotechnology is in a 
process of definition and stakeholders pave ways for it into research and policy, there is still no 
evidence for Marine Biotechnology becoming a relevant economic sector. Though great 
technological developments always comprise high risk, it would be responsible to scale down 
expectations a little bit and to face and to name also the risk of failure.   
 
 
  
Krost P. and T. Staufenberger. 2012: Sustainable aquaculture and climate change (German), EUCC 
Deutschland. Küste und Meer 3:39.  
Piker L. 2007. Mariculture - solution or meander (German)? EUCC Deutschland, Küste und Meer 
2007: 28. 
Piker L. 2010. Algae against cancer – New active components for oncology (German), GIT-
Laborfachzeitschrift 9/2010, Marine Biotechnologie – Life Science: 678-680. 
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INDUSTRY PERSPECTIVES AND EUROPABIO’S PROPOSED PUBLIC 
PRIVATE PARTNERSHIPS IN INDUSTRIAL BIOTECH 
Nathalie Moll 
EuropaBio, Avenue de l’Armée 6, 1040 Brussels, Belgium 
E-mail: n.moll@europabio.org  
Europe must seek to improve its capacity to innovate through bringing the results of research to 
market when compared with its worldwide competitors such as China, the US, India and Brazil. 
Although part of the problem is lower spending of GDP on research and development a bigger issue 
is that the EU takes too long to transform research and innovation results into marketable products 
and historically has lacked the support mechanisms to bridge the EU ‘innovation valley of death’. 
However, with the European Commission’s proposal for a new European Strategic Framework for 
Research and Innovation, Horizon 2020, the EU has taken a decisive step towards improving its 
competitiveness. The proposed approach is the right one: to focus on developing demonstration 
biorefineries and to develop access to risk finance and partnerships for the development of 
sustainable bio-based products, processes and services. These moves will help Europeans to take 
advantage of the social, economic and environmental benefits of the bioeconomy. 
EuropaBio is therefore calling on the EU Member States to support Horizon 2020 by endorsing 
research and innovation in industrial biotechnology, and the bioeconomy including through the 
Public Private Partnerships (PPP) BRIDGE (Biobased and Renewable Industries for Growth and 
Development in Europe) and through safeguarding the budget allocated to both the Bioeconomy 
and to Industrial Biotechnology as a Key Enabling Technology. 
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AN INTEGRATIVE ACADEMIC-INDUSTRY COLLABORATION FOR 
BIOTECHNOLOGY-DRIVEN DISCOVERY OF NEW FUNCTIONS IN MARINE 
ENVIRONMENTAL METAGENOMES 
Renzo Kottmann
1
 and Frank Oliver Glöckner
1,2 
1 
Microbial Genomics and Bioinformatics Research Group, Max Planck Institute for Marine 
Microbiology, Celsiusstr. 1 , 28359 Bremen , Germany 
E-mail: rkottman@mpi-bremen.de  
2
 Jacobs University, Campus Ring 1, 28759 Bremen, Germany 
 
The large scale integrated FP7 EU project ‘Marine Microbial Biodiversity, Bioinformatics and 
Biotechnology’ (Micro B3, www.microb3.eu) builds on the expertise of 25 academic and 7 industrial 
partners. This highly interdisciplinary consortium comprises world-leading experts in 
bioinformatics, computer science, biology, ecology, oceanography, bioprospecting and 
biotechnology, as well as legal aspects. Micro B3 is set out to create innovative bioinformatic 
approaches and a legal framework to make large-scale data on marine viral, bacterial, archaeal and 
protistic genomes and metagenomes accessible to marine ecosystems biology and to define new 
targets for biotechnological applications. 
 
The talk will outline the challenges faced integrating high volumes of heterogeneous data from 
biodiversity, genomic, oceanographic and earth observation databases into one Micro B3 
Information System (MB3-IS), based on global standards for sampling and data processing. The 
developed standards, legal framework as well as analysis tools and pipelines will be immediately 
put to test in Micro B3’s ‘Ocean Sampling Day (OSD)’. OSD is planned as a simultaneous, 
coordinated sampling campaign of the world’s oceans on summer solstice (June 21st) 2014. The 
resulting integrated datasets will provide insights into fundamental rules describing microbial 
diversity and function, and will contribute to the blue economy through the identification of novel, 
ocean-derived biotechnologies.  
 
The consortium values open access to data and open source software products which are based on 
clear communication of intellectual property rights. This open, integrative and cross domain spirit 
has created a stimulating environment for academic-industry cooperation for integrated software 
development and the discovery of new processes and enzymatic functions in marine metagenomic 
data. 
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SOCIAL SCIENCE INFORMED SUPPORT SYSTEMS TO BETTER 
UNDERSTAND THE EUROPEAN MARINE BIOTECHNOLOGY LANDSCAPE 
AND INNOVATION LINKS 
Antoine Schoen
1
, Patricia Laurens
2
 and Douglas Robinson
3
 
1
 Université Paris-Est, ESIEE–LATTS–IFRIS, 2 bd Blaise Pascal, 93160 Noisy-le-Grand, France 
E-mail: a.schoen@esiee.fr    
2
 Université Paris-Est, CNRS–LATTS–IFRIS, 2 bd Blaise Pascal, 93160 Noisy-le-Grand, France  
3
 TeqNode, 282 rue Saint Jacques, 75005 Paris 5, France 
 
Interest in Marine Biotechnology is increasing, and the potential fruits that could be harvested from 
a well-organised Marine Biotechnology community means that support tools that can inform 
coordination are necessary (a key driver for a Marine Biotechnology ERA-NET). 
 
Such coordination would benefit from social sciences-based support systems, and we propose three 
ways that such a support system could be put to work: 
 
 social sciences could help better understand the current marine 
biotechnology landscape by tracing the Marine Biotechnology community, its activities and degree 
of collaboration, the central hubs and those on the periphery, the existing industry academia 
collaborations. This knowledge will help identifying emerging ‘Innovation Pathways’ between 
research and industry. 
 
 qualitative forward-looking exercises can assess the growth potential for the 
main applications of marine biotechnology (e.g. seafood, drugs, biofuels and other marine 
biotechnology output that can foster the bioeconomy). 
 
: recent developments of technology have shown how critical has 
become the social acceptability of new technological knowledge, as seen from recent experiences in 
green biotech, nanotechnology and more recently synthetic biology. At the crossroad of genomics, 
nanotechnology and synthetic biology, marine biotechnology will face an important challenge in 
convincing a large array of stakeholders that, on the one hand, it does not build on irresponsible 
knowledge, and, on the other hand, it can fulfill the numerous promises it has announced. Such a 
perspective could help identifying the main bottlenecks that could impede the development of this 
technology and could therefore provide guidance in dealing with the corresponding policy issues 
with a view to the recent European move to Responsible Research and Innovation. 
 
 
Arnaud-Haond S., J.M. Arrieta, C.M. Duarte. 2011. Analysing marine biodiversity and gene patents. 
Science 331(6024):1521-1522. 
Gurney T., A. Schoen, E. Horlings, K. Sumikura, P. Laurens, P. Van Den Besselaar and D. Pardo. 
2012. Knowledge capture mechanisms in bioventure corporations. 17th International 
Conference on Science and Technology Indicators (STI), 5-8 September 2012. Montreal, 
Quebec, Canada. 
Robinson D.K.R., L. Huang, Y. Guo and A.L. Porter. 2012. Tracing promising nanotechnologies for 
diseases prevalent in ageing populations. Presentation at 2nd Global TechMining Conference. 
Montreal, Quebec, Canada. September 5
th
, 2012. 
Robinson D.K.R. and A. Rip. 2012. Socio-economic dynamics of innovation and uptake. Joint 
OECD/NNI International Symposium on Assessing the Economic Impact of Nanotechnology. 
Washington. March 27- 28. 
Robinson D.K.R. 2013. Controlled speculation about potential combinations of Nanotechnology and 
governance arrangements: structured social science informed scenarios. Chapter in ‘Proceed 
with Caution?: Concept and Application of the Precautionary Principle in Nanobiotechnology’. 
Lit Verlag. 
Robinson D.K.R., L. Huang, Y. Guo and A.L. Porter. 2013. Forecasting Innovation Pathways (FIP) for 
new and emerging science and technologies, Technology Forecasting and Social Change, 
doi:10.1016/j.techfore.2011.06.004. 
Schoen A., T. Könnölä, P. Warnke, R. Barré and S. Kuhlmann. 2011. Tailoring foresight to field 
specificities. Futures 43(3):232–242. 
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INDUSTRIAL BIO, MARINE BIO AND BIO-BASED ECONOMY 
Cees M.J. Sagt  
DSM Biotechnology Center, Alexander Fleminglaan 1, 2600 MA. Delft, the Netherlands 
Cees.Sagt@dsm.com  
The Biobased economy is one of the strategic growth areas for DSM. Energy and materials will be 
made from plant biomass in the future and DSM is developing technology for this. The biobased 
economy is here to stay, there is no other alternative. In this field algae technology will play an 
important role as well. However there are several breakthrough steps needed to turn phototrophic 
algae technology into an economical viable option. This presentation sketches the position of algae 
technology in the biobased economy and key steps for a successful implementation of phototrophic 
algae technology are discussed. Options for cost price reduction of algae biomass are presented 
and DSM’s view on technology breakthroughs which are needed to achieve this, will be explained. 
 
The different markets for algae biomass (regionally and functionally) are tightly linked to cost price 
reductions needed to unlock these market potentials. A stepwise development from high value 
product to commodity products which are produced by phototrophic algae technology is the most 
realistic way forward. This roadmap for the future of algae technology will conclude this 
presentation. 
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PANEL DISCUSSION 2  
Academic-industry collaborations: lessons for the future  
: Torger Børresen 
DTU Food, Denmark  
   
It is generally accepted that successful development of a strong marine biotechnology sector in 
Europe can only materialise taking an industry-academic collaborative approach. How can we gain a 
better understanding of the marine biotechnology sector, existing and potential knowledge 
networks and transfer mechanisms to support its role in the future European bioeconomy in order 
to meet the grand challenges outlined in the Horizon 2020 vision? How can national and European 
science policy efforts and support mechanism, and in particular a future ERA-NET, be developed and 
deployed to overcome the existing barriers, involve industry and foster industry-academic 
collaboration? To this end this panel will bring together key representatives from the scientific 
community, industry and regional clusters to discuss the challenges, opportunities and needs to 
gain a better understanding of the sector to improve links between industry and academic research 
efforts. 
 
Participants present their perspectives on successful industry-academic collaborations followed by a 
moderated discussion culminating in a clear set of recommendations. 
 
Selected representatives from the scientific community, industry and regional clusters. 
 
 , University of Minho (UM), Portugal 
 , Chair of the Marine Biotech committee of Pôle-Mer Bretagne (regional cluster in 
Brittany), France  
 , Aquapharm, UK 
 , Biobank of Arctic Marine Organisms (Marbank), Norway 
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SUBMARINER – TOWARDS A REGIONAL NETWORK TO STRENGTHEN 
THE ROLE OF BLUE BIOTECHNOLOGY WITHIN THE BALTIC SEA REGION  
Angela Schultz-Zehden
1
, Steffen Lüsse
2
 and Imke Schneemann
3
 
1
 SUBMARINER Project Coordination Office c/o Sustainable Projects s.Pro GmbH Rheinstr. 34, 12161 
Berlin, Germany 
E-mail: asz@sustainable-projects.eu  
2
 Ministry of Economic Affairs, Employment, Transport and Technology of the Land Schleswig-
Holstein, Initiative „Sea Our Future’ Düsternbrooker Weg 94, 24105 Kiel, Germany   
E-Mail: steffen.luesse@wimi.landsh.de  
3
 Norgenta North German Life Science Agency Wissenschaftspark Kiel, Fraunhoferstraße 2, 24118 
Kiel, Germany  
E-mail: imke.schneemann@norgenta.de  
 
The Baltic Sea Region faces enormous challenges including new installations, fishery declines, 
excessive nutrient input, the effects of climate change as well as demographic change. At the same 
time blue-green innovations and use combinations of new maritime and marine products and 
technologies may contribute to the creation of a bio-based economy stimulating blue growth also in 
disadvantaged coastal regions as well as improving the marine environment.  
 
Overall awareness of the potential for innovative and sustainable uses of Baltic marine resources is 
still low. Thus the so-called ‘SUBMARINER compendium’ (Schultz-Zehden & Matczak, 2012) has been 
designed as to provide for the first time a comprehensive assessment of their potentials. Topics 
covered macroalgae harvesting & cultivation, mussel cultivation, reed harvesting, large-scale 
microalgae cultivation, blue biotechnology, wave energy, sustainable fish aquaculture and 
combinations of such uses with offshore windparks. For blue biotechnology the state-of-the-art 
within all Baltic Sea Region countries has been mapped, further applications evaluated, technical 
requirements defined, economic aspects considered and existing strategies analysed.  
 
It has been shown that the marine organisms within the Baltic Sea show great potential for 
exploration with the added advantage of cost-efficient access under clear legal conditions. Research 
centres exist in almost all BSR countries with special expertise in all different Blue Biotechnology 
fields as well as in the operation of necessary equipment for biotechnology. Some investment is 
needed in order to develop sufficient upscaling of equipment and related quality assurance 
processes.  
 
What is most needed, however, is a focused Baltic Sea wide strategy for the implementation of Blue 
Biotechnology, based on national strategies and being aligned with the EU level. Such pan-Baltic 
strategy should consider most urgent market needs and make use of complementarity of national 
strengths improving modalities of technology transfer, making better use of existing support 
technologies and platforms while strengthening application-oriented approaches and ensuring that 
blue biotechnology is truly blue and sustainable, i.e. to the benefit of the sea.  
 
In addition to the pan-Baltic compendium, Norgenta, the life science agency of Hamburg and 
Schleswig-Holstein, developed a master plan for marine biotechnology in Schleswig-Holstein within 
the framework of the SUBMARINER project. Schleswig-Holstein, Germany´s northernmost federal 
state is known as the ‘land between the seas’. Its economy is closely linked to the North Sea and the 
Baltic Sea. Marine Biotechnology as a promising future technology is expected to become an 
integral part of it. To implement integrated maritime policy Schleswig-Holstein launched the 
initiative ‘Sea our Future’ already in 2004 and the so-called ‘Masterplan for Marine Biotechnology in 
Schleswig-Holstein’ (Klose et al., 2013) will now be one part of it. But it may serve as a model for a 
long-term development strategy for other countries around the Baltic Sea Region as well. The 
process included identification of the main industrial topics and markets (nutraceuticals, renewable 
energy, functional food, active pharmaceutical ingredients, cosmetics, and aquaculture) as well as 
academic topics (marine genomics, marine microbial diversity, biologically active substances, 
biobanking, and biopolymers). An overview of products and services already on the market was 
conducted. In addition, stakeholder panels were put in place to participate in this process to 
develop ideas for future actions. Charged by the Cabinet of Schleswig-Holstein, the Ministry of 
Economic Affairs, Employment, Transport and Technology Schleswig-Holstein will generate an 
implementation concept until the end of summer 2013. 
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It is expected, that the recommendations of the SUBMARINER project formulated within its Roadmap 
2020 to be published in summer 2013 will form the basis for new actions to be taken up by the 
future SUBMARINER flagship initiative, which has recently been approved under the revised 
European Union Strategy for the Baltic Sea Region.   
 
 
Klose D., R. Duckert, I. Kröger, T. Frahm and I. Schneemann. 2013. Masterplan Marine 
Biotechnologie Schleswig-Holstein – eine regionale Entwicklungsstrategie. Kiel & Hamburg. 
Schultz-Zehden A. & M. Matczak (Eds). 2012: SUBMARINER Compendium. An Assessment of 
Innovative and Sustainable Uses of Baltic Marine Resources. Gdansk. 
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GLOBAL PERSPECTIVES ON MARINE BIOTECHNOLOGY SCIENCE AND 
TECHNOLOGY POLICY  
Jacqueline Allan, Rachael Ritchie and Jim Philp 
Science and Technology Policy Division, Directorate for Science, Technology and Industry (OECD),  
2 rue André-Pascal, 75775 Paris Cedex 16, France 
E-mail: jacqueline.allan@oecd.org  
Scientific advances - the development of technology and tools to access and study marine 
organisms and ecosystems - are increasing our knowledge of marine biodiversity. Marine 
bioresources are a source of novel products and processes, yet remain largely untapped. Through 
biotechnology we have the potential to help to address the global challenges of food and energy 
security and of health, and to contribute to green growth and sustainable industries. But it is 
imperative that we maintain a sustainable relationship between the conservation and use of marine 
bioresources.  
 
The application of biotechnology to the marine raises distinctive challenges for policy makers. The 
vast interconnected systems of oceans contribute to the regulation of the planet's temperature and 
atmospheric conditions and currents carry marine life, nutrients and wastes within and across 
national borders. Governance of our shared marine environment presents challenges related to both 
access to and development of marine resources.  
 
The work at the OECD Division for Science and Technology Policy considers the twin tensions of 
ocean productivity and sustainability faced by those seeking to realise the potential of marine 
biotechnology. It seeks to identify the potential of the field and the support required to realise that 
potential, and explores the challenges – and possible next steps for policy development - to 
sustainable development, recognising the unique features of the marine environment and 
maximising the integrity and sustainability of that ecosystem for future generations. 
 - 28 -  
PERSPECTIVES FROM THE EUROPEAN COMMISSION DG RTD ON THE 
ROLE OF MARINE BIOTECHNOLOGY IN HORIZON 2020 
Guiu Etxeberria Garbiñe 
Directorate-General for Research and Innovation (DG RTD) – European Commission, Place Rogiers 
16, 09/24, B-1049 Brussels, Belgium 
E-mail: garbine.guiu@ec.europa.eu   
Biotechnology plays a vital role in the competitiveness of the European economy – from health care 
and pharmaceuticals to industrial processing, primary production and food. Biotechnology enables 
the development of medicines tailored to the specific needs of individual patients, of more efficient 
ways to use scarce resources like biomass and water and of new processes for the production of 
essential chemicals, food additives and materials while protecting our environment. Europe is in the 
lead in many of these areas, and our biotechnology industries have an important role to play for 
economic growth and job creation. 
 
With the largest part of the world biodiversity still undiscovered in the oceans, biotechnology is an 
essential enabling technology to open new avenues for exploring and exploiting the huge potential 
of marine resources for innovative products and applications.  
 
Boosting marine innovation through biotechnology-related activities is specifically mentioned in 
Horizon 2020: under the priority ‘Better Society’. In particular under the Challenge ‘Food security, 
sustainable agriculture, marine and maritime research and the bio-economy’ marine biotechnology 
will support the development of sustainable approaches to further explore and exploit the large 
potential offered by marine biodiversity and aquatic biomass to bring new innovative processes, 
products and services on the markets with potential application for example in sectors including 
chemical, biochemical and material industries, pharmaceuticals, fisheries and aquaculture or energy 
and biofuels supply.  
 
Under the priority ‘Competitive Industries’, key enabling technologies marine biotechnology will be 
further advanced for use in multiple sectors, industries and services using a new, technology-driven 
approach.  
 
At the heart of Horizon 2020 objectives will also be the need to develop cross cutting marine and 
maritime scientific and technological knowledge with a view to unlock the blue growth potential 
across the marine and maritime industries. This strategic coordinated approach for marine and 
maritime research across all challenges and pillars of Horizon 2020 will be key to support the 
implementation of relevant Union policies and to help deliver blue growth objectives. 
 
The objective to better align and link national research efforts with European research 
collaborations moving towards a coherent pan-European science policy and coordination for Marine 
Biotechnology Research perfectly fits HORIZON 2020 aims. 
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PERSPECTIVES FROM THE EUROPEAN COMMISSION DG MARE ON THE 
ROLE OF MARINE BIOTECHNOLOGY IN THE EC BLUE GROWTH 
STRATEGY AND THE INTEGRATED MARITIME POLICY (IMP) 
Rodríguez Sebastián 
Directorate-General for Maritime Affairs and Fisheries (DG MARE) – European Commission 
Joseph II 79, 02/047, B-1049 Brussels, Belgium 
E-mail: sebastian.rodriguez-alfaro@ec.europa.eu  
The Integrated Maritime Policy (IMP) seeks to provide a more coherent approach to maritime issues, 
with increased coordination between different policy areas focusing on issues that do not fall under 
a single sector-based policy e.g. ‘Blue growth’ and issues that require the coordination of different 
sectors and actors e.g. ‘Marine knowledge’. Therefore the IMP seeks to coordinate, not to replace 
policies on specific maritime sectors. 
 
The concept of the blue economy is a new one, looking at maritime sectors as a whole, rather than 
at individual sectors. The synergies between maritime and coastal activities are evident: skills are 
largely transferable between sectors, the sectors are to some extent inter-dependent, and they all 
rely on use of the sea in a sustainable way. Many of them also stand to benefit and grow from the 
development of new marine technologies and the growth of economic activity offshore. 
 
‘Blue growth’ is a long-term strategy to support growth in the maritime sector as a whole. It aims to: 
Identify and tackle challenges affecting all sectors of maritime economy, to highlight synergies 
between sectoral policies, to study interactions between the different activities and their potential 
impact on the marine environment and biodiversity and to identify and support activities with high 
growth potential in the long term. 
 
An analysis of the employment-creation potential, as well as the potential of research and 
development to deliver technology improvements, has suggested that the following five value 
chains could deliver sustainable growth and jobs in the blue economy: blue energy, aquaculture, 
maritime, coastal and cruise tourism, marine mineral resources and blue biotechnology. 
 
The blue biotechnology sector is expected to develop on three phases: In the very short term, the 
sector is expected to emerge as a niche market focused on high-value products for the health and 
cosmetic sectors. By 2020, it would grow as a medium-sized market producing metabolites and 
primary compounds (lipids, sugars) as inputs for the food and feed processing industries. In a third 
stage, in around 15 years' time and subject to technological breakthroughs, the biotechnology 
sector could become a provider of mass product markets. 
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TOWARDS AN ERA-NET IN MARINE BIOTECHNOLOGY 
Steinar Bergseth 
The Research Council of Norway, Stensberggt. 26, 131 Oslo, Norway 
E-mail: stb@rcn.no 
The CSA MarineBiotech project has been successful in the establishment of a network of funding 
organisation, stakeholders and programme managers interested in joint support for marine biotech 
research and development. A proposal for an ERA-NET in Marine Biotechnology (ERA-MBT) was 
submitted (February 2013) in response to the last FP7 call of theme 2: Food, Agriculture and 
Fisheries, and Biotechnology. If awarded, this ERA-NET will aim to take-off late 2013 for a duration 
of 4 years and will involve 20 partners from 14 countries. 
 
The ERA-MBT is designed to deliver better coordination of relevant national and regional Research, 
Technology Development and Innovation (RTDI) programmes in Europe, reducing fragmentation and 
duplication, and paving the way for common programmes and cooperation in the provision and use 
of research infrastructures and knowledge. This is a necessity to make sustainable use of the 
unique resources of the marine environments for the benefit of Europe’s development into a 
bioeconomy based society. 
 
ERA-MBT will work with stakeholders from industry and organisations to identify needs and gaps in 
the value chain from research and development, through optimising research results for proof of 
concept and industrial uptake and valorisation. At least three transnational calls will address these 
challenges, and cooperations with complementing activities will be explored to add value and power 
to enable the development of a horizontally applicable technology like marine biotechnology.  
 
In doing so, it will advance progress in this field towards the vision of a European Research Area 
(ERA)1 and promote and position marine biotechnology as a tool which can deliver “smart, 
sustainable and inclusive growth”, a core objective of the Europe 2020 Strategy2. 
 
 
 
1
 http://ec.europa.eu/research/era/index_en.htm  
2
 http://ec.europa.eu/europe2020/index_en.htm  
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PANEL DISCUSSION 3  
How to strengthen pan-European science policy and 
coordination for Marine Biotechnology Research  
: Steinar Bergseth 
RCN, Norway  
 
One of the long term goals as identified by many previous science policy events and documents 
entails the need to improve coordination between the various programmes, policies and support 
initiatives at national, macro-regional and pan-European level. The future ERA-NET will play an 
important role in this regard but on the long run other initiatives such as the JPI Oceans may also 
play an important role. Another key question is how to deal with the lack of dedicated support 
mechanisms at the national level in some countries and the disparity between the approaches of 
others. To this end this panel will bring together key representatives from national and regional 
organisations as well as leaders of relevant pan-European science coordination initiatives to discuss 
the challenges, opportunities and needs for better linking/collaboration of national, regional and 
pan-European marine biotechnology policies and programmes. 
 
Participants will present their background, experience and perspectives followed by a moderated 
discussion culminating in a clear set of recommendations. 
 
Selected representatives from national funding agencies and/or representative organisations, 
macro-regional collaborations and pan-European initiatives. 
 
 , JPI Oceans, Norway 
 , Centre national de la recherche scientifique (CNRS), Euromarine, France 
 , Mediterranean Science Commission (CIESM), Monaco 
 , Stazione Zoological Anton Dohrn, European Marine Biological Resources Centre 
(EMBRC), Italy
 
 
 - 36 -  
 
 
 
 - 37 -  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
POSTERS 
 
 
 - 38 -  
 
 - 39 -  
EU FP7 BAMMBO: SUSTAINABLE PRODUCTION OF BIOLOGICALLY 
ACTIVE MOLECULES OF MARINE BASED ORIGIN 
Céline Allewaert, Annick Verween and Wim Vyverman 
Protistology and Aquatic Ecology , Sterre Complex, S8, Krijgslaan 281, 9000 Ghent, Belgium 
E-mail: celine.allewaert@ugent.be  
The current growing demand for marine resources, in particular High Value Added molecules 
(HVAB’s) could pose a serious threat to marine ecosystems and marine biodiversity. Instead of 
exploiting the natural marine resources, environmental friendly and economically sustainable ways 
for culturing organisms with economically interesting composition should be developed.  
 
BAMMBO addresses all key issues associated with the culture of marine organisms and will 
overcome these bottlenecks by designing economically sustainable and scalable culturing 
methodologies for industrial scale production of HVAB’s. BAMMBO will screen and identify a broad 
range of marine organisms (e.g. bacteria, fungi, sponges, microalgae, macroalgae and yeasts) from 
diverse global locations for potential as sustainable producers of HVAB’s. BAMMBO will apply 
various analytical methods for the extraction, purification and enrichment of targeted bioactive 
compounds. Moreover, a detailed life cycle analysis of the production pathways developed in the 
project will be undertaken to fully evaluate the sustainability of production of biologically active 
products from marine organisms. 
 
The EU funded FP7 project BAMMBO started in 2011. BAMMBO has brought together a 
multidisciplinary consortium of specialist research and SME partners. The knowledge and 
technologies developed during the project is transferred to relevant stakeholders in industry and 
the research community, as well as to policy-makers. Innovative technologies developed in the 
project will be demonstrated with the involvement of industry partners, and the results will be of 
interest not only to companies directly involved in the marine sector, but to other large scale 
industry players such as pharmaceutical companies with interest in added-value bioactive 
compounds. 
 
The laboratory of Protistology and Aquatic Ecology (PAE), Ghent University has focused on HAVB’s 
derived from microalgae. Three microalgal species: Phaeodactylum tricornutum, Cylindrotheca 
closterium and Haematococcus pluvialis were selected by the consortium as model species. All three 
are producers of bioactive molecules: EPA, fucoxanthin and astaxanthin, respectively. The 
production of HVAB’s is often elicited by the alteration of environmental and nutrimental 
parameters, so called abiotic stressors. PAE has focused on the optimization of growth, harvest and 
screening of P. tricornutum, C. closterium and H. pluvialis. The elicitation of secondary metabolites 
was investigated in vitro at the flask scale by measuring metabolite production in response to 
various stresses. 
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THE PLACE OF SUSTAINABLE AQUACULTURE IN ‘BLUE GROWTH’ 
STRATEGY FOR THE BALTIC SEA  
Leonid Bugrov  
Laboratory of Aquaculture Innovation Technologies, Federal Scientific Institution of Fisheries 
GosNIORH, 199034 Makarova nab., 26, St.-Petersburg, Russia  
E-mail: leonid_bugrov@mail.ru  
Among the Baltic Sea countries only Finland has essential fish farming production based on marine 
aquaculture. The amount of food fish cultivated in Finland in 2010 was about 11.8 million 
kilograms. Value of food fish production was EUR 44.0 million. The food fish supply consisted of 
11.0 million kilograms of rainbow trout, about 0.7 million kilograms of whitefish (Coregonus 
lavaretus) and just under 0.1 million kilograms of other food fish species. The major part (80%) of 
farmed fish is from the seawaters. However the potential capacity of Baltic Sea is about 300 million 
kilograms for annual aquaculture total harvest. Just three of Baltic countries like Finland, Estonia, 
and Russia are able to produce up to 70 million kilograms in the Gulf of Finland waters. Nowadays 
the stake of European aquaculture is only 4,5% from the World production and fish farming in 
brackish water in Europe has the minor part. The Baltic Sea is a reserve for brackish water 
aquaculture growth in Europe. 
The Baltic Sea Region faces enormous challenges including fishery declines, eutrophication due to 
excessive nutrient input as well as the effects of climate change. But innovative technologies 
provide opportunities for new uses of marine ecosystems, which can be both commercially 
appealing and environmentally friendly (Blue Biotechnology in the Baltic, 2012). Nowadays typical 
aquaculture is intensive monoculture. This concept has several disadvantages both from an 
environmental point of view. The environmental pollution is a very important problem in the 
intensive fish farming. It is well known that salmon rearing causes the drift of 5-25% feed mass from 
the net cages. On the other hand polyculture production systems could represent ways of 
increasing production volume and utilizing the biodiversity of marine ecosystems. Combining cage 
system with an artificial reef could solve the problem of the waste conversion. The reefs installed 
around the cage become inhabited with various filtering organisms. Waste products from the cage 
might be used as food and contribute to the strengthening of bio-filtration belt, thus increasing the 
self-cleaning capability of the sea area (Bugrov, 1991). The most advanced systems are termed 
Integrated Multi-Trophic Aquaculture (IMTA) and combine the cultivation of fed species (e.g. finfish) 
with extractive species, which utilize the inorganic (e.g. seaweeds) and organic (e.g. suspension and 
deposit feeders) excess nutrients from the fed aquaculture (Marine Board-ESF, 2010).  
There are engineering and biological aspects that we need to consider as risk factors to provide an 
accurate estimation for sustainable aquaculture development in the Baltic Sea. Among engineering 
aspects the main is risk of damage of floating cages because conventional floating cages at water 
surface cannot withstand storm waves and ice fields. Key biological aspects are wave impact to fish 
and overheating in the summer season. Submersible cage system is the solution for offshore 
aquaculture. This is the way to avoid conflicts between users, reduces risk of fish overheating, cage 
damage by storms, drifting rubbish or ice and enables successful fish farming in open sea areas. At 
ice-infested waters submersible cages could be used for all-year round and seasonal fish farming. 
Before winter time cages will sink into safety depth to prevent the ice hazard (Bugrov, 2006). IMTA 
sea farms based on a submersible concept are able to produce different fin fish species, macro 
algae (Furcellaria lumbricalis) and blue mussels (Mytilus edulis) as row material for new 
pharmaceutical and cosmetics products, as well as may be a way to remove nutrients from the Baltic 
Sea. 
 
  
Bugrov L. 1991. Fish-farming cages and artificial reefs: complex for non-waste technology - 
Abstracts of Fifth International Conference on Aquatic Habitat Enhancement, 3-7 November, 
1991. Long Beach, California, USA. p.25. 
Bugrov L. 2006. The ‘Sadco’ underwater fish-farming system /’Underwater Technology & Ocean 
World’, Scientific and Technical Journal about World Ocean Resources Development 1:34-45. 
Blue Biotechnology in the Baltic Sea Region. 2012. New Strategies and Future Perspectives. 
Perspectives from the SUBMARINER Blue Biotechnology Cooperation Event. Kiel, Germany, 9–10 
May 2012. 
Marine Board-ESF Position Paper 15. 2010. Marine biotechnology: a new vision and strategy for 
Europe. 2010. 
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The Baltic Sea is one of the world’s largest brackish waters. To use its resources in an economical 
and environmental-friendly way, 19 institutions from 8 countries work on the 3-year-project 
‘SUBMARINER - Sustainable Uses of Baltic Marine Resources’. In an already published compendium, 
solutions for new innovative applications together with coordinated cross-border implementations 
are highlighted. This compendium is the guide and basis for politicians and stakeholders for a 
positive development of the Baltic Region. Additionally, a network is generated which should be 
expanded further after the finished project. 
 
In Mecklenburg-Vorpommern (Germany), BioCon Valley MV e.V. is working on marine functional 
genomics as part of the chapter ‘blue biotechnology’ in the compendium.  
With modern molecular biological methods the theoretical genomic potential as well as specific 
activities of microorganisms or their products can be estimated. New metabolic activities and 
adaptation strategies can be developed with model organisms, bioactive substances can be isolated 
from distinct organisms for use in the pharma-, cosmetic- and food industry and the environment 
can be monitored and protected. 
With the Ernst-Moritz-Arndt-University and the Institute of Marine Biotechnology e.V. (IMaB), 
Greifswald is one of the main players in biotechnology research in Germany. Experience as well as 
prominent platform technology is excellent with marine proteomics as a unique selling point.   
 
The poster gives more insights in the possibilities to transfer research in marine genomics in 
applicable techniques to better understand the microbial life in the Baltic Sea, improve the 
environment and use the bioresources to positively develop the whole Baltic Sea Region. 
 
 
www.submariner-project.eu 
www.bcv.org 
 - 42 -  
THE EUROPEAN JOINT PROGRAMMING INITIATIVE FOR HEALTHY AND 
PRODUCTIVE SEAS AND OCEANS (JPI OCEANS) 
Willem De Moor 
JPI Oceans, Troonstraat 130, 1050 Brussel, Belgium 
E-mail: willem.demoor@vliz.be  
The European Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans) is a 
coordinating and integrating platform, open to all EU Member States and Associated Countries who 
invest in marine and maritime research. In its role as a coordination platform JPI Oceans is the only 
high-level strategic body that exists, to provide a long-term integrated approach to marine and 
maritime research and technology development in Europe. 
 
While bringing together the interested Member States and Associated Countries JPI Oceans aims to 
add value by avoiding fragmentation and unnecessary duplication; planning common and flexible 
initiatives; facilitating cooperation and foresighting; and establishing efficient mechanisms for 
interaction and knowledge transfer between the scientific community, industry & services, and 
policy makers at high level to more effectively solve the grand challenges. 
 
As a coordination platform, JPI Oceans focuses on making better and more efficient use of national 
research budgets, which represent 85% of the marine-maritime funding within Europe. One of the JPI 
goals is to develop joint research programs in which countries can be involved on a voluntary basis 
(variable geometry). Participating countries will also decide what contribution to make: this may 
include institutional, project-related or new funds. 
 
JPI Oceans is run by a high-level Management Board with representatives from each country with 
sufficient authority to agree on joint action plans and potential funding initiatives across all sea 
basins in Europe. 
 
The Management Board has put in place a Strategic Advisory Board of high-ranked  representatives 
from science, industry, public authorities and civil society to advise on future actions to be taken. 
 
The daily follow up of the JPI is taken care of by the JPI Oceans secretariat which is based in Brussels 
 
 
Website: www.jpi-oceans.eu 
Twitter: @jpioceans 
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Italy is finally looking ahead towards the Mediterranean Sea, therefore intensifying its exchanges 
with the neighbouring countries, and investing more and more in activities designed to sustainably 
exploit the sea. The awareness of the socio-economic and cultural importance of the 8,000 km of 
coastline have incited the Italian industry and research system to implement a national programme 
of scientific and technological research for the sea, pluri-annual and open to the participation of all 
public and private stakeholders.  The RITMARE objectives aim at promoting a significant evolution 
of the national economy of the sea, supporting networking, co-operation and internationalization 
actions in harmony with the indications of the Blue Book.   
Partners of the project are, public research organisations: CNR, INGV, OGS, SZN, ENEA, CONISMA, 
CINFAI, private sectors, Technology Districts: Sicilia NAVTEC, DLTM, AgroBioPesca, DITENAVE; 
industries: Fincantieri, CETENA, CONSAR, UNIMAR, RINA and authorities appointed to the 
management, monitoring and safeguard of marine environment, Ministry of Education, University 
and Research. A special attention will be paid to support integrated policies for the safeguard of the 
environment (the health of the sea); to enable sustainable use of resources (the sea as a system of 
production); to implement a strategy of prevention and mitigation of anthropogenic or natural 
impacts (the sea as a threatened system; the sea as a potential source of risks for humans). 
RITMARE partially overlaps with the Marine Biotechnologies CSA as to the following activities: 1) 
Bioprospecting for the detection of molecules and biological processes in deep-seas with potential 
applications in biotechnology (Goods and ecosystem services provided by deep marine 
environments) 2) Innovation in aquaculture, 3) Development of new green approaches for the 
recovery of contaminated waters associated with spills of toxic and / or hazardous substances to 
timely respond to these events.  
By means of its network, which includes researchers of various disciplines and industrial partners, 
RITMARE will facilitate new multi-sector partnerships (i.e. including those concerned by bio-
medicals/pharmacology). More particularly, the transfer of knowledge and technology across the 
various collaborating sectors, relying on the National Research Council facilities, will be carried out 
by means of a targeted dedicated office. From the very early stage of the project, this office will be 
responsible for market potential assessments, and will assist researchers in the definition of 
contracts, in tasks related to the management of intellectual property and for the filing of patent 
applications. It will also provide support during the phases of prototyping and engineering, and will 
look for partners potentially interested to acquire the produced patents. The possibility of 
facilitating the creation of new high-tech companies (spin-off) is also envisaged. This task will be 
fulfilled via entrepreneurial training programs, business planning and preliminary support to the 
management and coordination of the business incubator. 
While being a national project, RITMARE can integrate (or inspire) other at international (i.e. 
European) level. 
The Italian maritime zones harbour various ecosystems with great potential for bioprospecting. 
Among various, shallow hydrothermal vents (Panarea, Vulcano, Ischia), submarine volcanoes 
(Marsili, Palinuro), mud volcanoes (Strait of Sicily, Calabria dorsal), hypersaline anoxic lakes (Ionian 
sea) offer unique opportunities to study the adaptive mechanisms of micro- and macro fauna to the 
extreme conditions, and the possible inter-species interactions (including symbioses) allowing their 
survival in such harsh environments  
Bioprospecting activities, especially aiming to search for bioactive molecules and enzymatic 
reactions with potential industrial applications will be carried out by means of a large set of modern 
methodologies, including (meta) genomics, (meta) transcriptomics and (meta) proteomics. 
optimised screening platforms. Once isolated, compounds with biotechnological potential will be 
characterized chemically. Among the possible applications, bioremediation treatments for the 
recovery of oil-polluted marine environment will be a priority target. 
 
www.ritmare.it  
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Metagenomic surveys, like the Global Ocean Survey (GOS), generated a huge amount of genetic data 
and allow performing more holistic approaches to study marine ecosystems. Moreover, 
metagenomics proofed being valuable in discovering missing pieces in marine biological processes. 
However, metagenomics not only expanded our limited view on the diversity of the known protein 
universe, it also increased the number of genes of unknown functions. Metagenomics reveals a 
large number of known unknowns like the domains of unknown function (DUF) and unknown 
unknowns, putative coding sequences without any hint of potential function. Here we propose a 
novel approach to extract valuable information from the co-occurrence of individual protein 
domains involved in biological processes in metagenomic complex systems using Graphical Models. 
Using an integrative approach, we combine the knowledge of the known protein domain families 
and 16S rDNA with the unknown unknowns to explore the GOS metagenome. As a result, we are 
able to reveal new associations in biological processes within known protein families and between 
known protein families and unknowns.  
 
In conclusion, our approach provides a better understanding of the known biological processes and 
generates a list of candidates from the unknowns or unknown unknowns related with known 
processes for experimental verification. In some cases we could even suggest specific cultured 
organisms for performing lab experimental on genes of unknown functions. Thus, our approach 
might play an important role in bioinformatics biodiscovery pipelines for biotechnology. 
 
 
 - 45 -  
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The Kiel Center for Marine Natural Products (Kieler Wirkstoff-Zentrum KiWiZ) is a biotechnological 
research platform for marine natural products specifically from marine microorganisms covering 
aspects from the habitat to the hit for drug candidates. It has built up national, European and 
international networks to promote the research on bioactive substances from the laboratory to 
industrial application. The activities of KiWiZ include research on ecological aspects of natural 
products as well as on their biotechnological production. It performs studies on the biology and 
chemistry of marine natural products and their producers, marine bacteria and fungi. The 
exploration of the marine microbial biodiversity with respect to natural products, the development 
of methods for their biotechnological production with minimized risks for nature and man as well 
as their sustainable use is considered by KiWiZ. 
 
The focus of the KiWiZ at GEOMAR is on identification, production and promotion of new natural 
products from marine microbial sources and the investigation of their biological activities and 
ecological function. Studies of the KiWiZ include all aspects from sampling, isolation and 
identification of the microorganisms in order to describe biodiversity, their preservation in culture 
collections, revelation of genomic potentials, as well as the extraction, purification, structure 
elucidation and characterisation of natural products from the cultured bacteria and fungi in order to 
describe and understand chemodiversity of marine microbes. In addition, optimisation of 
production conditions and scale up to a pilot scale for biotechnological production of bioactive 
natural products are considered as part of a sustainable approach for marine biotechnology. The 
research of KiWiZ relies on the extremely high diversity of marine microorganisms either newly 
cultured with special intention or contained in the large culture collections of KiWiZ containing 
marine bacteria and fungi covering more than 15.000 isolates, with a high proportion of new and 
unknown taxa. Important aspects became the growing panel of biological assay systems, in which 
suitability for specific applications is tested and the establishment of a substance library of pure 
marine natural products. With its unique setup and resources, the KiWiZ has developed into an 
excellent scientific centre on new natural products from marine microorganisms, being operated by 
an interdisciplinary team of scientists. Basic aspects on both biology and chemistry of marine 
natural products as well as applied research topics are considered. In addition to numerous 
publications and several patents, the strategy of KiWiZ in the frame of marine natural product 
research is included in a recent review on this topic (Imhoff et al., 2011). Highlights of the research 
activities of KiWiZ and its networks will be presented. 
 
 
 
Imhoff J.F., A. Labes and J. Wiese. 2011. Biomining the microbial treasures of the ocean: new natural 
products. Biotechnol Advances 29:468-482. 
 - 46 -  
FP7 PROJECT KILL•SPILL: INTEGRATED BIOTECHNOLOGICAL 
SOLUTIONS FOR COMBATING MARINE OIL SPILLS 
Nicolas Kalogerakis
1
 and Philippe Corvini
2
 
1 
Department of Environmental Engineering, Technical University of Crete, Polytechneioupolis, 
Chania 73100, Greece 
E-mail: nicolas.kalogerakis@enveng.tuc.gr  
2
 University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, 
Institute for Ecopreneurship, Gründenstrasse 40, 4132 Muttenz, Switzerland 
 
Oil spill disasters are a worldwide problem and current technologies do not satisfactorily address 
the issue. It is important to recognize that ‘miracle microorganisms’ and ‘magic elixirs’ sprinkled on 
an oil spill will not do the job. An integrated approach considering at the same time: (1) metabolic 
requirements of biodegrading organisms alongside the properties of the oil, (2) environmental 
limitations on oil biodegradation and (3) innovative delivery mechanisms for agents that alleviate 
these bottlenecks is critical. This is the essence of the Kill Spill project. It represents a European 
initiative fully committed to tackle oil spill disasters in an integrated and interdisciplinary fashion 
employing highly efficient remediation strategies. 
 
The principal objective of Kill•Spill (http://www.killspill.eu/) is to develop highly efficient, 
economically and environmentally viable solutions for the clean-up of oil spills caused by maritime 
transport or offshore oil exploration and related processes, which have been fully validated in large 
mesocosm facilities under controlled conditions and by application to real life oil spills. In general, 
once crude oil is spilled, it takes at least one week before biodegradation processes begin to take 
effect. Kill•Spill aims to shorten this start up period to the absolute minimum by providing 
technologies for example, that provide the necessary nutrients together with hydrocarbon 
degrading consortia and/or enhancing compounds (biosurfactants) to both accelerate and 
maximize bioremediation rates from the time of application. In addition, when the use of 
dispersants is recommended, the previously mentioned biostimulation and bioaugmentation 
formulations will be applied together with specific compounds acting as dispersants that take the 
oil from the surface to the water column and ultimately to the sea floor. Taking into account that as 
we go deeper in the water column, the amount of dissolved oxygen is more difficult to replenish by 
diffusion, Kill•Spill also offers specific novel technologies (OxygelTM and AerobeadsTM) that release 
oxygen over longer periods of time. It maintains as a result greater bioremediation rates of 
dispersed oil in the water column, even when it reaches the sediments. In cases where it is not 
feasible, this approach will be complemented with the development of processes to stimulate oil 
biodegradation anaerobically in anoxic sediments. Once the dispersed oil reaches the sediments, 
bioremediation rates are substantially reduced due to the prevailing anoxic conditions. Kill•Spill 
provides a series of highly innovative technologies (e.g., ‘Kill•Spill snorkel’, ‘Kill•Spill Robot’, 
‘Kill•Spill Sed-Cleaner’) that overcome this problem and induce enhanced biodegradation rates in 
the sediments. These technologies can also be used for the remediation of recurrently polluted 
sediments (from old oil spills) in all types of environments from the Eastern Mediterranean to Disko 
Bay in Greenland. In addition, several other innovative products will be developed, e.g., ‘Kill•Spill 
All-in-One’, ‘Kill•Spill Deep-sea’, ‘Kill•Spill Bio-boom’, besides the ‘Kill•Spill Biosensor’ for in situ 
monitoring of oil degradation. 
 
The Kill Spill project involves 14 universities, 4 research institutions, 14 SMEs and one spill industry 
trade association active in complementary areas, contributing to the development of innovative and 
integrated solutions and tailored strategies for the oil spill cleanup market. The solutions 
developing from the Kill●Spill project are evaluated against current industry solutions, and 
promoted to the European spill industry through conferences and seminars. Thus, Kill Spill 
consortium will generate new industrially driven foreground and deliver innovative processes and 
services to policy makers and European citizens. The Kill Spill project has also much to offer to the 
Marine Strategy Framework Directive (MSFD). For example, all the technologies developed for 
hydrocarbon polluted sediments can be part of the mitigation measures to return marine 
environments to Good Environmental Status (GES). Furthermore, the monitoring tools can be used 
by Member States in the requested initial assessment to identify current environmental status. 
Moreover, many of the Kill Spill biostimulation strategies can be applied to sea areas faced with 
chronic pollution. 
 
This project is supported by the European Commission in the 7
th
 Framework Programme under 
Grant Agreement 312139 within FP7- KBBE.2012.3.5-01. 
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The European Marine Biological Resource Centre (EMBRC; www.embrc.eu) will comprise a distributed 
ESFRI Research Infrastructure of key European marine biological and molecular biology laboratories, 
together providing: 1) access to European coastal marine biota and ecosystems; 2) an integrated 
supply of marine organisms for interdisciplinary research, including models; 3) coordinated services 
including biobanks and platforms for genomics, structural and functional biology, microscopy and 
bioinformatics; 4) interdisciplinary training in marine biological sciences and genomics; and 5) 
outreach and consultancy. New and improved services will be provided for research, training, 
education and innovation. EMBRC targets users from across the biological, biomedical, geochemical 
and environmental sciences, from the public (academia, government, NGO) as well as the private 
sector (industry, SME), wishing to apply state-of-the-art approaches to study marine model 
organisms. EMBRC is currently in its third year of the preparatory phase with founding partners 
from Italy, France, Germany, Greece, Norway, Portugal, Sweden, and the UK together with aspiring 
partners from e.g. Belgium, Denmark, Israel and the Netherlands wishing to join in the 
implementation and construction phase. EMBRC plans to obtain ERIC status and is currently 
developing a Memorandum of Understanding with business plan and consortium agreement. The 
operational EMBRC will contribute to finding coherent solutions for exploiting the full economic 
potential of the seas in a sustainable way, minimizing the impact on the marine environment, 
following EUROPE 2020 and MARINE KNOWLEDGE 2020 objectives. 
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The aim of the FP7 funded project MARINE FUNGI is the demonstration of sustainable exploitation 
of marine natural resources providing appropriate culture conditions for the underutilised group of 
marine fungi, thus enabling efficient production of marine natural products in the laboratory and 
also in large scale cultures, avoiding harm to the natural environment. 
 
The focus of MARINE FUNGI are new anti-cancer compounds The project carries out the 
characterisation of these compounds to the stage of in vivo proof of concept ready to enter further 
drug development in order to valorise the results of the project. MARINE FUNGI covers two 
approaches to gain effective producer strains: a) Candidate strains originating from one partner’s 
strain collection are characterised and optimised using molecular methods; b) New fungi are 
isolated from unique habitats, i.e. tropical coral reefs, endemic macroalgae and sponges from the 
Mediterranean. Culture conditions for these new isolates are optimised for the production of new 
anti-cancer metabolites. MARINE FUNGI will develop a process concept for these compounds 
providing the technological basis for a sustainable use of marine microbial products as a result of 
‘Blue Biotech’. The project explores the potential of marine fungi as excellent sources for useful 
new natural compounds. This is accomplished by the formation of a new strongly interacting 
research network comprising the scientific and technological actors, including 3 SMEs and 2 ICPC 
partners, necessary to move along the added-value chain from the marine habitat to the drug 
candidate and process concept. The generated and existing knowledge will be disseminated widely 
for the valorisation of the project results. 
 
 
  
www.marine fungi.eu  
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The Flemish Algae Platform is a  funded by the 
Flanders Innovation Hub for Sustainable Chemistry (FISCH).  
 
Microalgae are photosynthetic microorganisms that abound in the world’s oceans, rivers and lakes. 
These algae offer many new opportunities. Applications of microalgae cover a broad spectrum, 
including the food and (livestock) feed industries, chemicals, bioenergy, cosmetics, healthcare and 
environmental restoration or protection. These applications also come with many challenges to 
produce sustainably on large scale. The goal of the Flemish Algae Platform project is to create a 
 linking Flemish organisations (companies, research institutions and associations) that 
currently have activities concerning microalgae or that have plans to do so in the future. This 
network will  and encourage the embedding of existing algae activities and the 
development of new microalgae related business activities.  
 
Activities which will be carried out in this project aim to  the various 
actors in the algae value chain and support them with the implementation of their innovation 
process. The Flemish Algae Platform will also  
, creating a favorable environment for the 
development of a Flemish microalgae economy. In the field of microalgae there is a strong need for 
such a project because of the strategic importance and the early development stage of most of the 
activities and collaborations. 
 
The Flemish Algae Platform is open for all stakeholders active or interested in algae. More 
information about membership can be found on our website: www.vlaamsalgenplatform.be. 
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Enzymes isolated from marine archaea, bacteria and algae offer potential for use in industrial 
biocatalysis. At the Exeter Biocatalysis Centre, we have studied several such enzymes including 
vanadium haloperoxidases from marine algae, dehalogenases from several marine bacterial species 
in collaboration with Aquapharm, UK, L aminoacylase, alcohol dehydrogenase and lysophosholipase 
from marine isolated thermophilic archaea and marine viral proteins. 
 
These activities have application for the synthesis of pharmaceutical intermediates. Many of the 
enzymes have novel properties from their counterparts isolated from other environments.  
The presentation will include details on enzyme discovery, cloning, characterisation including X-ray 
structural determination and molecular modelling.  
 
We are also part of a large EU grant 'Hotzyme' where we will also be including discovery of 
hydrolase enzymes from marine environments. 
 
 
Guy J.E., M.N. Isupov and J.A. Littlechild. 2003.  The structure of an alcohol dehydrogenase from the 
hyperthermophilic archaeon Aeropyrum pernix. J. Mol. Biol. 331:1041-1051. 
Isupov M.N., A.R. Dalby, A.A. Brindley, Y. Izumi, T. Tanabe, G.N. Murshudov and J. Littlechild. 2000. 
Crystal structure of dodecameric vanadium dependent bromoperoxidase from the red algae 
Corallina officinalis.  J. Mol. Biol. 299:1035–1049. 
Littlechild, J., E. Garcia Rodriguez and M. Isupov. 2009. Vanadium containing bromoperoxidase – 
Insights into the enzymatic mechanism using X-ray crystallography. Journal of Inorganic 
Biochemistry 103:617-621. 
Novak H.R., C. Sayer, M.N. Isupov, K. Paszkiewicz, D. Gotz, A. Mearns Spragg and J.A. Littlechild. 
2013. Marine Rhodobacteraceae L-haloacid dehalogenase contains a novel His/Glu dyad which 
could activate the catalytic water. Febs J. in press. 
Toogood,H.S., E.J. Hollingsworth, R.C. Brown, I.N. Taylor, S.J.C. Taylor, R. McCague and  J.A. 
Littlechild. 2002. A thermostable L-aminoacylase from Thermococcus litoralis: cloning, 
overexpression, characterization, and applications in biotransformations. Extremophiles 6:111–
122. 
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Many marine resources could be used by marine biotechnology in order to be transformed into 
food, medicine, cosmetics and energy. The marine biotechnology is not restricted at creating new 
industrial products; it could also contribute to the bio-economy and grand societal challenges. The 
golden triangle of blue growth (marine resources, demand and market development, product and 
innovation) shows that marine biotechnology has a high potential in strengthening the regional 
economic development and in allowing a more sustainable use of marine resources. However, many 
problems exist in the process of marine resource uptake (availabilities, transportation costs, 
marketing conditions). The present work relates two case studies of regional development focusing 
on algae and co-products of fisheries and aquaculture in Brittany (France) and Tohoku (Japan). This 
study aims to: 1) identify opportunities and constraints for the development of marine 
biotechnology using Value Chain Analyses; and 2) identify public-private partnerships in the areas 
of research and innovation and market development (poles, clusters). Constraints and opportunities 
are based on the organisation of the sector and the links with the regional economy. The golden 
triangle of blue growth will be examined to a regional level rising questions as: Is the regional 
marine food industry adapted to a better use of living marine resources? What are the main barriers 
to a regional level for an efficient organisation of the marine biotechnology industry? Public-private 
partnerships have to improve technology transfer pathways by strengthening the basis for proactive 
interaction between academic research and industry. What is ‘the state of art’ on marine 
biotechnology and is there a technological transfer between academic research and the industry on 
a regional basis? 
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Marine organisms live in an adverse and aggressive environment, however, most of them either lack 
an adaptive immune system (invertebrates) or possess a very primitive one (fish). The immune 
defence of these animals is mainly based on strong innate system effector molecules to fight 
against potential pathogens. In the last years new genomic tools, such as high-throughput 
sequencing methods, have helped us to identify an important repertory of putative immune genes 
in non model animals constituting a defence system as rich and complex as that of mammals. We 
have focused mainly on aquacultured animals, both fish and shellfish. In spite of the relevance of 
aquaculture and the associated pathological process, knowledge about these animals’ immune 
system is still fragmentary and little is known about host-pathogen interactions. The aim of our 
work was to increase the genomic resources of fish (turbot), and shellfish (mussel, clam) particularly 
the transcriptome in response to pathogen stimulations to identify the main components of their 
immune pathways. 
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The SPECIAL project aims at delivering breakthrough technologies for the biotechnological 
production of cellular metabolites and extracellular biomaterials from marine sponges. These 
include a platform technology to produce secondary metabolites from a wide range of sponge 
species, a novel in vitro method for the production of biosilica and recombinant technology for the 
production of marine collagen. 
 
Research on cellular metabolites is based upon our recent finding that non-growing sponges 
continuously release large amounts of cellular material. Production of biosilica is being realized 
through biosintering, a novel enzymatic process that was recently discovered in siliceous sponges. 
Research on sponge collagen is focussed on finding the optimal conditions for expression of the 
related genes. 
 
Alongside this research, the project is identifying and developing new products from sponges, thus 
fully realizing the promises of marine biotechnology. Specifically, the project is focussed on 
potential anticancer drugs and novel biomedical/industrial applications of biosilica and collagen, 
hereby taking advantage of the unique physico-chemical properties of these extracellular sponge 
products. 
 
The consortium unites seven world-class research institutions covering a wide range of marine 
biotechnology-related disciplines and four knowledge-intensive SMEs that are active in the field of 
sponge culture, drug development and nanobiotechnology. 
 
The project is clearly reflecting the strategic objectives outlined in the position paper European 
Marine Strategy (2008); it will enhance marine biotechnology at a multi-disciplinary, European level 
and provide new opportunities for the European industry to exploit natural marine resources in a 
sustainable way. In particular, the biotechnological potential of marine sponges, which has for a 
long time been considered as an eternal promise, is definitely being realized through the SPECIAL 
project. 
 
Up to now, some project results can be highlighted: 
 Collection and characterisation of various species of sponges from different habitats, namely 
Mediterranean Sea, Red Sea, Azores and Caribbean Sea (Curaçao); 
 Successful mariculture of two species of marine sponges; 
 Extraction and characterisation of collagen from one species of sponge; 
 Characterisation of genes regulating collagen expression on sponges; 
 In-vitro culture of sponge cells with a primmorph development state; 
 Screening of sponge extracts and subsequent fractions for anti-tumor activity in order to identify 
bioactive compounds; 
 Development of nature made scaffolds for tissue engineering approaches from the collagen 
native structure of several sponge species: 
 Delivery of newsletters, available through the project website (http://www.project-special.eu/) 
 Production of videos on project topics (within Marine Biotechnology), available through the 
project SPECIAL YouTube channel (http://www.youtube.com/user/projectSPECIALeu); 
 Organisation of Open Days about project outputs and Marine Biotechnology (Italy and Israel). 
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APROPOS – Added value from high oil and high protein industrial co-streams – is a collaborative 
research project which addresses the FP7 KBBE-2011-5 topic BioWASTE – Novel biotechnical 
approaches for transforming industrial biowaste to bioproducts. The project started in January 2012 
and will last until December 2014. 
 
The main objective of APROPOS is to develop and optimize a techno-economically feasible and 
sustainable wasteless process based on benign, organic solvent-free fractionation technologies for 
the exploitation of fish filleting and rapeseed residues as raw materials, ingredients and additives 
for food and skin care formulations as well as chemicals for pesticides and soil improvement. 
 
APROPOS consortium consists of 7 academic partners and 10 SMEs from the EU, India, Kenya and 
Uganda as well as Norway and Canada. The project will lead to greater integration of research 
actors and activities from across the EU, North America, Africa and Asia by utilising two raw 
materials with distinct origin but many similarities. This will integrate researchers and their 
competences from rapeseed and fish processing as well as from biotechnology and R&D in food and 
skin care sectors and processing industries. 
 
The success of technological developments will be assessed in terms of economic feasibility, raw 
material efficiency and environmental impacts. The project will also study, how the developed 
residue producer-end use value chain affects the existing residue – feed/ energy -value chain. 
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In an aging community, defects in knee cartilage ending in knee replacements with artificial joints 
become a serious problem. A low-cost method to delay these severe intrusions is thus requested. 
We present a new material from a marine source for cartilage tissue engineering. Pure collagen from 
jellyfish Rhopilema esculenta is used to cast a porous, dry sponge. On this matrix, chondrocytes are 
seeded and implanted into a cartilage defect where they are thought to reproduce new hyaline 
cartilage. 
 
Several matrices for MACI (matrix-induced chondrocyte implantation) were developed from bovine 
or porcine collagen, thus they all produce unwanted fibrous cartilage and bear the risk of passing 
diseases like BSE. 
 
The new matrix from jellyfish collagen shows important advantages over other matrices. This 
collagen has similarities to vertebrate collagen-type II, the main type in healthy hyaline cartilage. 
Coming from an invertebrate, there is no risk of passing BSE or initiation of arthrosis by 
inflammation. Culture experiments with porcine chondrocytes showed a reproduction of hyaline 
cartilage, having a very high collagen-type II fraction. Additionally, stiffness of the matrix could be 
adjusted to aim a tissue-specific matrix. Porcine chondrocytes responded to varied stiffnesses with 
different collagen-type II and I patterns. On a less rigid matrix (2 kPa) chondrocytes preserved their 
phenotype better than on a stiffer matrix (20 kPa). This could be the fundament for engineering not 
only cartilage but also other tissues like skin or bone on the basis of jellyfish collagen. 
 
 
  
Krost P. and T. Staufenberger. 2012: Sustainable aquaculture and climate change (German), EUCC 
Deutschland, Küste und Meer 3/2012:39.  
Piker L. 2010. Algae against cancer – New active components for oncology (German), GIT-
Laborfachzeitschrift 9/2010, Marine Biotechnologie – Life Science:678-680. 
Piker L. 2007. Mariculture - solution or meander (German)? EUCC Deutschland, Küste und Meer  
2007: 28 
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The 4-year SPLASH project will develop a new biobased industrial platform using microalgae as a 
renewable raw material for the sustainable production and recovery of hydrocarbons and 
(exo)polysaccharides from the species Botryococcus braunii and their further conversion to 
renewable polymers. The project comprises 20 partners of which 40% SME and several large 
corporates plus universities and research institutes. 
 
Two bioproduction platforms will be explored: (i) green alga Botryococcus braunii on its own and (ii) 
the green microalga Chlamydomonas reinhardtii, to which the unique hydrocarbon and 
polysaccharides producing genes from Botryococcus will be transferred. SPLASH will deliver 
knowledge, tools and technologies needed for the establishment of a new industry sector: Industrial 
Biotechnology with algae and/or algal genes for the manufacture of polyesters and polyolefins. The 
building blocks for these polymers will be derived from the sugars (polyesters) and hydrocarbons 
(polyolefins) exuded by the algae: adipic acid from galactose, 2,5-furandicarboxylic acid from 
glucose, 1,4-pentanediol from rhamnose and fucose, ethylene from ‘green naphtha’ and propylene 
from ‘green naphtha’. The conversion of ethylene and propylene to polyolefins is common 
technology, and will not be included in the project. The sugar-derived building blocks will be 
converted to new condensation polymers, such as e.g. poly (ethylene 2,5-furandioate) (PEF). End-use 
applications include food packaging materials and fibres for yarns, ropes and nets. The project 
encompasses: (1) development of Botryococcus as an industrial production platform, (2) systems 
biology analysis, (3) development of processes for production, in situ extraction and isolation, (4) 
product development. More detailed information including project partners and coordination can be 
found at  www.eu-splash.eu  
 
SPLASH receives funding from the European Community's Seventh Framework Programme (FP7) 
under the grant agreement No. 311 956. 
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ELIXIR is a distributed Research Infrastructure for the life sciences. It will ensure that researchers 
throughout Europe have access to the biological data they need to address pressing challenges in 
marine science, from the loss of biodiversity to food safety and security. These are issues of such 
complexity that no one institute, company, country or continent can tackle alone.  
ELIXIR harnesses and builds upon Europe’s strengths in bioinformatics. The central co-ordinating 
Hub is based alongside EMBL-EBI on the Wellcome Trust Genome Campus in Hinxton, UK, with 
nodes distributed throughout centres of excellence in the participating member states. At present, 
EMBL and the following fifteen countries are ELIXIR members: Czech Republic, Denmark, Estonia, 
Finland, Greece, Italy, Israel, Netherlands, Norway, Portugal, Slovenia, Sweden, Spain, Switzerland 
and the UK.  
Discoveries in marine sciences increasingly involve computational methods. These range from 
aquaculture to using marine natural products for pharmaceutical development through to the 
monitoring of pollution, and have great potential for improving quality of life and environmental 
protection. Equally, these are also disciplines where European industry can thrive, helping to drive 
competitiveness, employment and growth.   
The Norwegian ELIXIR Node
i
 will provide services and resources toward marine genomics including 
researchers, government, and industry. The Norwegian Node will offer several integrated packages 
geared towards large-scale analysis of marine genomic and metageniomic data (e.g. fish genomics 
and marine bioprospecting). This also includes provision of web-based solutions for services, 
toolboxes, and computational access to reference data provided by the ELIXIR infrastructure. 
Researchers in academia and industry already make great use of existing bioinformatics resources 
to carry out marine research: in addition to leading services provided by the Norwegian ELIXIR Node, 
other services run by ELIXIR partners include the European Nucleotide Archive (ENA
ii
) and UniProt
iii
, 
which have many sequences from marine species, and Ensembl genomes, which includes genomes 
from some marine organisms. Additionally, there are also a number of marine metagenomics 
datasets on the European Bioinformatics Institute’s metagenomics portaliv. 
The BioMedBridges
v
 project, which is coordinated by ELIXIR, is building connections between ELIXIR 
and the other ESFRI Research Infrastructures including the European Marine Biological Resource 
Centre (EMBRC)
vi
, with links to metagenomics data that will help characterise poorly understood 
ecosystems and to cheminformatics data to characterise the activity of isolated natural products.    
ELIXIR can act as the resource to store marine-based biological data generated through nationally-
funded research projects as well as through European programmes such as the Joint Programming 
Initiatives. Research projects funded through the JPI Oceans initiative are likely to generate large 
amounts of relevant data, which can be preserved, annotated and made available for further use by 
the ELIXIR infrastructure, ensuring maximum value for taxpayers.  
 
______ 
 
I 
http://www.bioinfo.no/  
ii
 http://www.ebi.ac.uk/ena/  
iii
 http://www.uniprot.org/  
iv
 https://www.ebi.ac.uk/metagenomics/  
v
 http://www.biomedbridges.eu  
vi
 http://www.embrc.eu  
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Marine macroalgae produce a wealth of different compounds with antioxidative potentials. 
Particularly the superoxide scavenging activities of polysulphated polysaccharides from different 
sources has been investigated. Fucoidans are heat stable antioxidants, able to effectively scavenge 
superoxide anions. This is in addition to, and independent from their other effects, such as anti-
coagulant activities. Different molecular fucoidan species with different superoxide-scavenging 
efficiency can be isolated with high yield, dependent on source material and purification method. 
Specific luminescence assays are employed to reliably quantify their antioxidative activities. Pure 
and well characterized fucoidans may have the potential to serve many different pharmaceutical and 
clinical applications. They may, for example, alleviate inflammatory symptoms caused by the 
formation of superoxide. Current cooperative projects implicate the screening of macroalgae from 
the Baltic Sea for fucoidan abundance. Thereby molecular weight distributions, superoxide-
scavenging activities, long-term stability, and optimisation of purification protocols are in the focus 
of our research. 
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CIIMAR - Interdisciplinary Centre of Marine and Environmental Research – (www.ciimar.up.pt is a 
research and advanced training institution associated to the University of Porto. It develops high-
quality research, promotes technological development and supports public policies in the area of 
marine and environmental Sciences. CIIMAR hosts 18 research groups, in 5 research lines, with a 
scientific staff of more than 250 researchers (125 PhD holders) with diverse backgrounds. CIIMAR 
contributes to the understanding of the biological, physical and chemical processes in the ocean 
and the coastal zones, to the sustainable use of aquatic resources and the evaluation of the impact 
of human activities on ecosystems. CIIMAR generated 700 publications in SCI-indexed 
journals in the last 3 years. Marine biotechnology is one of the main CIIMAR research areas, 
having our researchers collaborated in the ESF position paper that reported a new vision and 
strategy in this field (Borrensen et al., 2010). Natural products of marine origin, from cyanobacteria, 
fungi and sponges, have been studied at CIIMAR with the aim of finding new drugs such as 
anticancerigens (Almeida et al., 2010) or anti-viral (Lopes et al., 2011) drugs. Bioactive compounds 
from cyanobacteria may have allelopathic activity with potential use to control algal blooms or as 
antifouling in the marine environment (Leão et al., 2012). In the biomedical area we are also 
interested in the use of biological fluids such as those of Anodonta cygnea on the biomineralization 
of chitosan membranes (Lopes et al., 2010). Fish aquaculture has been researched with the purpose 
of meeting the growing demand for sustainable and healthy seafood by designing new 
environmental friendly diets that also increase performance and quality of farmed fish (Cabral et al., 
2011, Pérez-Jiménez et al., 2012). The potential use of naturally occurring microbial communities in 
bioremediation processes of hydrocarbons and emergent pollutants is also being studied (Almeida 
et al., 2013). CIIMAR wants to improve its technology transfer pathway to stimulate cooperation 
with industry and seeks international collaboration in marine biotechnology in the framework of 
Horizon 2020, namely in ‘Food security, sustainable agriculture, marine and maritime research and 
the bioeconomy’ issues. 
 
  
Almeida A.P., T. Dethoup, N. Singburaudom, R. Lima, M.H. Vasconcelos, M. Pinto, A. Kijjoa. 2010. 
The in vitro anticancer activity of the crude extract of the sponge-associated fungus Eurotium 
cristanum and its secondary metabolites. Journal of Natural Pharmaceuticals 1:25-29. 
Almeida M.R., I. Reis, M.N. Couto, A.A. Bordalo and A.P. Mucha. 2013. Potential of the microbial 
community present in an un-impacted beach sediment to remediate petroleum hydrocarbons. 
Environmental Science and Pollution Research. (in press) 
Borrensen T., C. Boyen, A. Dobson, M. Höfle, A. Lanora, M. Jaspars, A. Kijjoa, J. Olafsen, J. Querellou, 
G. Rigos and E. Wijffels. 2010. Marine Biotechnology: A new vision and strategy for Europe. 
Marine Board-ESF Position Paper 15:1-91. 
Cabral E.M., M. Bacelar, S. Batista, M. Castro-Cunha, R.O.A. Ozório and L.M.P. Valente. 2011. 
Replacement of fishmeal by increasing levels of plant protein blends in diets for Senegalese 
sole (Solea senegalensis) juveniles. Aquaculture 322-323:74-81. 
Leão P.N., N. Engene, A. Antunes, W.H. Gerwick and V. Vasconcelos. 2012. The chemical ecology of 
cyanobacteria. Natural Products Reports 29:372-391. 
Lopes A., M. Lopes-Lima, I. Bobos, J. Ferreira, S. Gomes, R. Reis, J. Mano and J. Machado. 2010. The 
effects of Anodonta cygnea biological fluids on biomineralization of chitosan membranes. 
Journal of Membrane Science 364:82-89.  
Lopes V.R., M. Schmidtke, M.H. Fernandes, R. Martins and V. Vasconcelos. 2011. Cytotoxicity in 
L929 fibroblasts and inhibition of herpes simplex virus type 1 Kupka viruses by estuarine 
cyanobacteria. Toxicology in Vitro 25:944-950.  
Pérez-Jiménez A., H. Peres, V. Cruz Rubio and A. Oliva-Teles. 2012. The effect of dietary methionine 
and white tea on antioxidant defenses and oxidative damage of Sparus aurata. British Journal of 
Nutrition. 108(7):1202-120. 
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Populations of sea trout Salmo trutta m. trutta L., cod Gadus morhua L. and mussels Mytilus spp. 
from the Baltic Sea were studied using SNPs (single nucleotide polymorphisms) genotyping methods 
in order to characterize their genetic differentiation. Sea trout, a migratory form of brown trout is 
represented by numerous populations in the Baltic Sea. Many populations are enhanced by releases 
of artificially reared alevins and smolts (supportive breeding). South East Baltic populations of 
migratory (from Poland, Lithuania, Denmark: Bornholm, Estonia and Russia) were genotyped with 
iPLEX Gold Sequenom method using a diagnostic panel of 23 SNPs. The highest level of pairwise Fst 
differences was observed between Russian population from East Gulf of Finland and Polish 
populations from the Baltic Main Basin and the lowest differences were between the both Polish, and 
Polish and Lithuanian populations. Genetic differences were found between 2 closely related Salmo 
trutta m. trutta populations in Poland by genotyping using an Atlantic salmon derived custom 
design Illumina iSelect SNP-array (Drywa et al., 2013). Selected transcripts putatively  involved in 
immune response, by using 454 pyrosequencing technology were studied in Vistula River 
specimens. A total of 1,440,373 reads were obtained with the average read length 334 nucleotides. 
At present, 3 groups of genes were identified: Mx, C7 and MHC. Differences in gene expression in 
hatchery Salmo trutta m. trutta and Oncorhynchus mykiss under stress caused by infection with a 
bacterial pathogen Aeromonas salmonicida spp salmonicida and non-infected were observed. Some 
genes were up-regulated (chaperones, mainly HSPs, Mx, interleukin IL17D a proinflammatory 
cytokine) and down-regulated (acute phase proteins, chemokines, cytokines, COX, lectins, lectin 
receptors and inflammation related proteases, TNF-related and apoptotic proteins and other) as 
found by the application of transcriptome hybridisations to 44K oligo-microarray (Agilent).  
Populations of cod were studied using 5 SNPs. According to the obtained HRM (high resolution 
melting) results populations of the Baltic cod were characterized by clinal variation of alleles at loci 
known to be linked with salinity gradient. The obtained results confirm that eastern population of 
cod is a separate population of Atlantic cod. Exposure of cod from western (Kiel) and southern 
(Gdansk) Baltic to different salinity ranging from 3 to 33ppt revealed its high tolerance to different 
environmental conditions. This tolerance is being studied at the level of gene expression and high 
number of SNPs.  
Baltic populations of Mytilus spp. are locally adapted, with a unique composition of loci derived 
from M. trossulus and M. edulis genome. To identify markers and genes associated with the hybrid 
zone in Danish Straits and to determine the uniqueness of Baltic populations, 60 polymorphic SNPs 
were used to genotype individual mussels from the Baltic, North Sea and Canada. In total 35 SNPs 
turned out to be significant in FST outlier analysis and therefore were clearly related to the 
interactions with environment.  The majority of new SNPs show greater participation of M. trossulus 
than M. edulis genes in the nuclear DNA of Baltic Mytilus. 
 
 
 
Drywa A., A. Poćwierz-Kotus, A. Wąs, S. Dobosz, M.P. Kent, S. Lien, R. Bernaś and R. Wenne. 2013. 
Genotyping of two populations of Southern Baltic Sea trout Salmo trutta m. trutta using an 
Atlantic salmon derived SNP-array. Marine Genomics 9:25–32. 
 
 
 
 
 
 
